Patient Safety Organizations: Voluntary Relinquishment From the Patient Safety Leadership Council PSO, 75401-75402 [2016-26144]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 210 / Monday, October 31, 2016 / Notices
Item No.
Bureau
Subject
4 ..............................
Enforcement ..........................................
5 ..............................
Wireline Competition .............................
Federal Communications Commission.
Marlene H. Dortch,
Secretary.
[FR Doc. 2016–26197 Filed 10–28–16; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL RESERVE SYSTEM
sradovich on DSK3GMQ082PROD with NOTICES
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than
November 15, 2016.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Blair M. Bowman, Brighton,
Michigan, and Peter D. Scodeller,
Beverly Hills, Michigan, together as a
group acting in concert; to acquire
additional voting shares of Huron Valley
Bancorp, Inc. and thereby indirectly
acquire Huron Valley State Bank, both
of Milford, Michigan.
B. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
VerDate Sep<11>2014
17:53 Oct 28, 2016
Jkt 241001
75401
Summary: The Commission will consider a Memorandum Opinion and Order
that dismisses and denies a Petition for Reconsideration of a Forfeiture
Order issued by the Commission for the deceptive marketing of prepaid calling cards.
Title: NobelTel, LLC.
Summary: The Commission will consider a Memorandum Opinion and Order
that dismisses and denies a Petition for Reconsideration of a Forfeiture
Order issued by the Commission for the deceptive marketing of prepaid calling cards.
Title: Protecting the Privacy of Customers of Broadband and Other Telecommunications Services Alerts (WC Docket No. 16–106).
Summary: The Commission will consider a Report and Order that applies the
privacy requirements of the Communications Act to broadband Internet access service providers and other telecommunications services to provide
broadband customers with the tools they need to make informed decisions
about the use and sharing of their information by their broadband providers.
1. The Judy Svajgr Trust dated June
24, 1983, Cozad, Nebraska, the Judy
Svajgr Trust dated March 20, 1997,
Cozad, Nebraska, and Kirk Randal
Riley, Cozad, Nebraska, individually
and as voting representative of the
foregoing trusts; to acquire voting shares
of Midwest Banco Corporation, and
thereby indirectly acquire voting shares
of First Bank and Trust Company, both
of Cozad Nebraska. In addition, the
Rebecca Akers Irrevocable Trust, Cozad,
Nebraska, the Kevin Olson Irrevocable
Trust, Cozad, Nebraska, the Keith Olson
2016 Irrevocable Family Trust, Colorado
Springs, Colorado, along with Rebecca
Anne Akers, Monument, Colorado,
Kevin Edward Olson, Colorado Springs,
Colorado, and Steven K. Mulliken,
Colorado Springs, Colorado, request
approval as members of the Olson/
Svajgr group acting in concert to control
Midwest Banco Corporation, and
thereby own shares of First Bank and
Trust Company, Cozad, Nebraska.
Board of Governors of the Federal Reserve
System, October 26, 2016.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2016–26223 Filed 10–28–16; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment From the
Patient Safety Leadership Council PSO
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
The Patient Safety and
Quality Improvement Act of 2005, 42
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
U.S.C. 299b–21 to b–26, (Patient Safety
Act) and the related Patient Safety and
Quality Improvement Final Rule, 42
CFR part 3 (Patient Safety Rule),
published in the Federal Register on
November 21, 2008, 73 FR 70732–
70814, establish a framework by which
hospitals, doctors, and other health care
providers may voluntarily report
information to Patient Safety
Organizations (PSOs), on a privileged
and confidential basis, for the
aggregation and analysis of patient
safety events. The Patient Safety Rule
authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule,
when a PSO chooses to voluntarily
relinquish its status as a PSO for any
reason, or when a PSO’s listing expires.
AHRQ has accepted a notification of
voluntary relinquishment from the
Patient Safety Leadership Council PSO
of its status as a PSO, and has delisted
the PSO accordingly. The Patient Safety
Leadership Council PSO submitted this
request for voluntary relinquishment
after receiving a Notice of Preliminary
Finding of Deficiency.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on September 30, 2016.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, Room 06N94B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
E:\FR\FM\31OCN1.SGM
31OCN1
75402
Federal Register / Vol. 81, No. 210 / Monday, October 31, 2016 / Notices
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
federally approved PSOs.
AHRQ has accepted a notification
from the Patient Safety Leadership
Council PSO, PSO number P0164, to
voluntarily relinquish its status as a
PSO. Accordingly, the Patient Safety
Leadership Council PSO was delisted
effective at 12:00 Midnight ET (2400) on
September 30, 2016. AHRQ notes that
the Patient Safety Leadership Council
PSO submitted this request for
voluntary relinquishment following
receipt of the Notice of Preliminary
Finding of Deficiency sent on
September 1, 2016.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.ahrq.gov.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2016–26144 Filed 10–28–16; 8:45 am]
BILLING CODE 4160–90–P
sradovich on DSK3GMQ082PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
VerDate Sep<11>2014
17:53 Oct 28, 2016
Jkt 241001
ACTION:
Notice.
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project: ‘‘Agency
for Healthcare Research and Quality’s
(AHRQ) Guide to Improving Patient
Safety in Primary Care Settings by
Engaging Patients and Families—
Evaluation.’’ In accordance with the
Paperwork Reduction Act, 44 U.S.C.
3501–3521, AHRQ invites the public to
comment on this proposed information
collection.
This proposed information collection
was previously published in the Federal
Register on August 11th, 2016 and
allowed 60 days for public comment.
AHRQ did not receive any substantive
comments. The purpose of this notice is
to allow an additional 30 days for public
comment.
DATES: Comments on this notice must be
received by November 30, 2016.
ADDRESSES: Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by
email at OIRA_submission@
omb.eop.gov (attention: AHRQ’s desk
officer).
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Proposed Project
Agency for Healthcare Research and
Quality’s Guide To Improving Patient
Safety in Primary Care Settings by
Engaging Patients and Families—
Evaluation
There is a substantial evidence base
showing that engaging patients and
families in their care can lead to
improvements in patient safety. Since
the 1999 release of To Err is Human,
there has been an undeniable focus on
improving patient safety and
eliminating patient harm within acute
care. What is not as well documented is
how to achieve these improvements in
primary care settings.
Patient and Family Engagement (PFE)
strategies for acute care settings include:
patient and family advisory committees;
membership on patient safety oversight
bodies at both operations and
governance levels; consultation in the
development of patient information
material; engaging patients in process
improvement or redesign projects;
rounding with patients and families;
patient and family participation in
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
clinical education programs, and
welcoming patients and families to
work alongside providers and health
systems employees on transparency,
culture change and high reliability
organization initiatives.
Although the field of PFE in patient
safety for hospitals and health systems
is maturing, leveraging PFE to improve
patient safety in non-acute settings is in
its infancy. Building sustainable
processes and practice-based
infrastructure are crucial to improving
patient safety through patient and
family engagement in primary care.
In response to the limited guidance
available for primary care practices to
improve safety through patient and
family engagement, the Agency for
Healthcare Research and Quality
(AHRQ) has funded the development of
a Guide to Improving Safety in Primary
Care Settings by Engaging Patients and
Families (hereafter referred to as the
Guide). The comprehensive guide will
provide primary care practices with
interventions that they can use to
engage patients and families in ways
that lead to improved patient safety. It
will include explicit instructions to help
primary care practices, providers, and
patients and families adopt new
behaviors. The Guide and its
development are prefaced on several
key insights relevant to primary care
including:
D Active engagement requires
organizational commitment to hearing
the patient and family voice and action
by leadership to include them as central
members of the health care team.
D Patients and families expect and
increasingly demand meaningful
engagement in harm prevention efforts.
D Institutional courage is required to
openly share patient safety
vulnerabilities and proactively engage
patients in developing solutions that
prevent harm.
D Supportive infrastructure is needed
to hardwire PFE into all facets of care
delivery across the care continuum.
D When done well, patient
engagement yields important and
measurable results. When not done
well, PFE activities may disenfranchise
patients, contribute to
misunderstanding about risk, result in
lack of trust between providers and their
organizations, and create fissures among
members of the clinical care team.
With these insights as a basis, three
precepts undergird our approach to
development for the Guide. The Guide
interventions must yield:
D Meaningful relationship-based
engagement for patients and families
and primary care providers.
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 81, Number 210 (Monday, October 31, 2016)]
[Notices]
[Pages 75401-75402]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26144]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment From the
Patient Safety Leadership Council PSO
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Act of 2005, 42
U.S.C. 299b-21 to b-26, (Patient Safety Act) and the related Patient
Safety and Quality Improvement Final Rule, 42 CFR part 3 (Patient
Safety Rule), published in the Federal Register on November 21, 2008,
73 FR 70732-70814, establish a framework by which hospitals, doctors,
and other health care providers may voluntarily report information to
Patient Safety Organizations (PSOs), on a privileged and confidential
basis, for the aggregation and analysis of patient safety events. The
Patient Safety Rule authorizes AHRQ, on behalf of the Secretary of HHS,
to list as a PSO an entity that attests that it meets the statutory and
regulatory requirements for listing. A PSO can be ``delisted'' by the
Secretary if it is found to no longer meet the requirements of the
Patient Safety Act and Patient Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ has accepted a notification of voluntary
relinquishment from the Patient Safety Leadership Council PSO of its
status as a PSO, and has delisted the PSO accordingly. The Patient
Safety Leadership Council PSO submitted this request for voluntary
relinquishment after receiving a Notice of Preliminary Finding of
Deficiency.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12:00
Midnight ET (2400) on September 30, 2016.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, Room 06N94B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local):
[[Page 75402]]
(301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local): (301)
427-1130; Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of federally approved PSOs.
AHRQ has accepted a notification from the Patient Safety Leadership
Council PSO, PSO number P0164, to voluntarily relinquish its status as
a PSO. Accordingly, the Patient Safety Leadership Council PSO was
delisted effective at 12:00 Midnight ET (2400) on September 30, 2016.
AHRQ notes that the Patient Safety Leadership Council PSO submitted
this request for voluntary relinquishment following receipt of the
Notice of Preliminary Finding of Deficiency sent on September 1, 2016.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.ahrq.gov.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2016-26144 Filed 10-28-16; 8:45 am]
BILLING CODE 4160-90-P
